1. Home
  2. PAHC vs SABR Comparison

PAHC vs SABR Comparison

Compare PAHC & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • SABR
  • Stock Information
  • Founded
  • PAHC 1946
  • SABR 2006
  • Country
  • PAHC United States
  • SABR United States
  • Employees
  • PAHC N/A
  • SABR N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • SABR Computer Software: Programming Data Processing
  • Sector
  • PAHC Health Care
  • SABR Technology
  • Exchange
  • PAHC Nasdaq
  • SABR Nasdaq
  • Market Cap
  • PAHC 946.9M
  • SABR 981.2M
  • IPO Year
  • PAHC 2014
  • SABR 2014
  • Fundamental
  • Price
  • PAHC $24.50
  • SABR $2.55
  • Analyst Decision
  • PAHC Sell
  • SABR Hold
  • Analyst Count
  • PAHC 4
  • SABR 4
  • Target Price
  • PAHC $20.00
  • SABR $4.15
  • AVG Volume (30 Days)
  • PAHC 288.4K
  • SABR 6.2M
  • Earning Date
  • PAHC 05-07-2025
  • SABR 05-07-2025
  • Dividend Yield
  • PAHC 1.97%
  • SABR N/A
  • EPS Growth
  • PAHC 140.17
  • SABR N/A
  • EPS
  • PAHC 0.78
  • SABR N/A
  • Revenue
  • PAHC $1,190,682,000.00
  • SABR $3,023,296,000.00
  • Revenue This Year
  • PAHC $28.33
  • SABR $6.71
  • Revenue Next Year
  • PAHC $13.78
  • SABR $5.20
  • P/E Ratio
  • PAHC $31.29
  • SABR N/A
  • Revenue Growth
  • PAHC 19.12
  • SABR 2.56
  • 52 Week Low
  • PAHC $16.16
  • SABR $1.93
  • 52 Week High
  • PAHC $26.55
  • SABR $4.63
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 63.39
  • SABR 43.39
  • Support Level
  • PAHC $23.58
  • SABR $2.44
  • Resistance Level
  • PAHC $25.26
  • SABR $2.69
  • Average True Range (ATR)
  • PAHC 0.79
  • SABR 0.11
  • MACD
  • PAHC 0.02
  • SABR -0.03
  • Stochastic Oscillator
  • PAHC 62.66
  • SABR 7.09

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About SABR Sabre Corporation

Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company also has a growing hotel IT solutions division (9% of revenue). Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.

Share on Social Networks: